FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
21/06/2025
Voltar para busca
Dado oficial do USPTO
THERALUGAND
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
THERALUGAND
ST13
US500000079383213Classe
1, 5, 42
Pedido
79383213
Registro
7602399
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
22/06/2023
Data de registro
17/12/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/12/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
16
Localização do titular
DE
Examinador
TWOHIG, SHANNON MARIE
Unidade examinadora
N30
Localização atual
TMO LAW OFFICE 121
Titulares e representantes
Titulares
Eckert & Ziegler Radiopharma GmbH
Representantes
Ursula B. Day law firm of Ursula B. Day
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Industrial chemicals; radioactive elements for scientific purposes; detergents for use in manufacture of radioactive substances; salts for industrial purposes; chemical substances for analyses in laboratoriesother than for medical or veterinary purposes; diagnostic preparationsother than for medical or veterinary purposes; isotopes for industrial purposes; chemical reagents other than for medical or veterinary purposes; salts being chemical preparationsindustrial salts; fissionable chemical elementsradioactive elements for scientific purposes; emollients for industrial purposes; enzymes for scientific purposes; dyes for scientific or research purposes; glycoprotein; immunoglobulinsbeing biological preparations for scientific useother than for medical use; immunoassay reagents for scientific purposesother than for medical use; immunological antibodies for scientific purposesother than for medical use; biomolecule labeling kits comprising reagents for use in scientific research; laboratory reagents for scientific use; tagged antibodies for scientific use; tagged antibodies for laboratory use; monoclonal antibodies for scientific use; proteins in raw form for use in science; proteins in raw form for scientific purposes for binding antibodies other than for medical use; reagents for scientific purposes; substances for scientific useradioactive substances; universal reagents for automated test systems for scientific purposes; diagnostic reagents for scientific or research use
Classe 5
Medical and veterinary preparationsradioactive preparations for use in treating cancer; biological reagents for medical use; biological reagents for veterinary use; diagnostic chemical reagents for medical use; diagnostic agents for pharmaceutical use; diagnostic biomarker reagents for medical purposes; immunoassay reagents for medical use; in vitro diagnostic preparations for medical use; clinical medical reagents; diagnostic reagents for medical use; clinical diagnostic reagents for medical or veterinary purposes; reagents for use in diagnostic pregnancy tests for medical or veterinary purposes; reagents and media for medical and veterinary diagnostic purposes; reagents for microbiological analysis for medical purposes; mineral salts for medical purposes; chemical preparations for medical purposesfor treatment of hormonal imbalances; chemical preparations for pharmaceutical purposesfor treatment of migraines; chemical preparations for veterinary purposeschemical reagents for veterinary use; chemico-pharmaceutical preparations for the treatment of gout; disinfectants; diagnostic preparations for medical use; pharmaceuticalveterinary and sanitary preparations for treatment of tumor diseases; radioactive substances for medical purposes
Classe 42
Science and technology servicesscientific research services; testingauthentication and quality controltesting of pharmaceuticalsquality control for others; bacteriological consultation and research; consultancy in the field of pharmaceutical research; consultancy relating to laboratory testing of materials; biological researchclinical research in the field of chemotherapy and medical research; medical research laboratory services; analysis of human serum for medical research; research and development in the pharmaceutical and biotechnology fields; medical research laboratory services relating to the production of monoclonal antibodies; research and development services in the field of antibodies; pharmaceutical research and development; consultancy relating to biotechnology; biochemical analysis; biochemistry research services; biological research; microbiological testing; preparation of scientific research reports in the biotechnology field; research and development services in the field of immunology
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
31/05/2025
FIMP
FINAL DISPOSITION PROCESSED
31/05/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/05/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
15/04/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
15/04/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
21/03/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
18/03/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
17/12/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
17/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29/10/2024
PUBO
PUBLISHED FOR OPPOSITION
29/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/10/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/09/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
16/09/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
16/09/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
16/09/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
16/09/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/09/2024
GNFR
FINAL REFUSAL E-MAILED
12/09/2024
CNFR
FINAL REFUSAL WRITTEN
12/09/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/09/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/09/2024
RFNT
REFUSAL PROCESSED BY IB
24/04/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/04/2024
RFRR
REFUSAL PROCESSED BY MPU
02/04/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
14/03/2024
CNRT
NON-FINAL ACTION WRITTEN
13/03/2024
DOCK
ASSIGNED TO EXAMINER
11/03/2024
MAFR
APPLICATION FILING RECEIPT MAILED
21/11/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/11/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
16/11/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace THERALUGAND ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.